Maxcyte (MXCT) Share-based Compensation (2020 - 2026)
Maxcyte (MXCT) posted quarterly Share-based Compensation of $1.1 million for Q1 2026, down 62.45% year-over-year from $3.0 million in Q1 2025, and up 61.61% quarter-over-quarter from $706000.0 in Q4 2025.
Maxcyte (MXCT) Share-based Compensation (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Share-based Compensation for 7 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 62.45% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $8.0 million (down 37.11% YoY), while the FY2025 annual figure was $9.2 million, down 29.58% from the prior year.
- Share-based Compensation grew to $1.1 million in Q1 2026 per MXCT's latest filing, from $706000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $20.7 million in Q3 2024 and bottomed at -$3.2 million in Q4 2022.
- Historically, Share-based Compensation has averaged $5.2 million across 5 years, with a median of $3.2 million in 2022.
- Annual changes were most pronounced in 2022 — Share-based Compensation sank 228.97% — and 2024, when it soared 473.54%.
- Maxcyte's Share-based Compensation stood at -$3.2 million in 2022, then surged by 213.18% to $3.6 million in 2023, then slipped by 12.31% to $3.1 million in 2024, then plunged by 77.47% to $706000.0 in 2025, then jumped by 61.61% to $1.1 million in 2026.
- Business Quant data shows MXCT's Share-based Compensation at $1.1 million in Q1 2026, $706000.0 in Q4 2025, and $14.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | 8.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.13 Mn |
| Jun 30, 2026 | 8.13 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 706,000.00 |
| Dec 31, 2025 | 706,000.00 |
| Sep 30, 2025 | 14.37 Mn |
| Sep 30, 2025 | 14.37 Mn |
| Jun 30, 2025 | 19.49 Mn |
| Jun 30, 2025 | 19.49 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 20.70 Mn |
| Sep 30, 2024 | 20.70 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |